Topic: How To Invest

Pat: Can I have your thoughts on Patient Home Monitoring?

Article Excerpt

Patient Home Monitoring, $0.26, symbol PHM on Toronto (Shares outstanding: 105.7 million; Market cap: $28.0 million; www.phmhometesting.com), plans to keep acquiring small firms that serve chronically ill patients in their homes. It then aims to increase its revenue per patient by offering all these companies’ services to its growing client base. In the three months ended December 31, 2013, the company’s revenue jumped to $2.4 million from $1.0 million a year earlier. It earned $140,294, or $0.0014 a share, compared to $140,120, or $0.0022, on fewer shares outstanding. Patient Home Monitoring holds cash of $8.5 million, or $0.08 a share, and has low debt. The aging population and rising incidence of chronic disease are expanding the company’s market. At the same time, the increasing cost of caring for patients in hospitals is leading to a push for more in-home care. However, Patient Home Monitoring’s growth-by-acquisition strategy adds risk. Patient Home Monitoring is okay to hold, but for highly aggressive investors only. only. …